Results 101 to 110 of about 10,586,463 (310)

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla   +6 more
wiley   +1 more source

Pre-empting technical barriers in the Single Market. CEPS Policy Brief No. 277, 11 July 2012 [PDF]

open access: yes, 2012
Effective enforcement and compliance with EU law is not just a legal necessity, it is also of economic interest since the potential of the Single Market will be fully exploited.
de Brito, Anabela Correia   +1 more
core  

Development of long axial range 3D single-particle tracking by PSF engineering using birefringent substrates [PDF]

open access: yes
We propose a new method to engineer point spread function (PSF) for 3D single-particle tracking using mica. The imaging system in this method uses a standard wide-field fluorescence microscope; the only difference from the ordinary is using a mica as a ...
Habuchi, Satoshi, Nozue, Shuho
core   +1 more source

Review of the current published evidence for single-dose HPV vaccination 4th Ediion [PDF]

open access: yes, 2022
The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine.
Single-Dose HPV Vaccine Evaluation Consortium
core  

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex   +13 more
wiley   +1 more source

Single-chip performance comparison. [PDF]

open access: yes, 2017
Single-chip performance comparison.
Haohuan Fu (3829738)   +7 more
core   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko   +19 more
wiley   +1 more source

Evaluation of Different Cultivars of Tuberose (Polianthes tuberosa L.) under Humid agro Climatic conditions of Goa

open access: yesJournal of Horticultural Sciences, 2019
Tuberose (Polianthes tuberosa L.) is one of the most important tropical bulbous-ornamental cultivated for production of long-lasting flowers spikes. Adaptation and acclimatization of different cultivars under humid agro-climatic conditions of Goa are to ...
Safeena S A, Thangam M, Singh N P
doaj   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol   +6 more
wiley   +1 more source

BMT4me En Español: Multisite Feasibility and Usability Testing of a Spanish‐Language mHealth Adherence Support App for Spanish‐Speaking Caregivers of Children After Hematopoietic Stem Cell Transplantation and Cancer Treatment

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy